GGrantIndex
Sort

11,323 grants matching glioblastoma

Combined Pre & Intraoperative Brain Tumor Imaging Strategy using a Dual-Modality

$178,740
Moritz Florian Kircher · Sloan-Kettering Inst Can Research · K08 · FY2013 · CA

Combined Pre & Intraoperative Brain Tumor Imaging Strategy using a Dual-Modality

$178,740
Moritz Florian Kircher · Sloan-Kettering Inst Can Research · K08 · FY2015 · CA

Optimizing CAR T therapy via metabolic engineering for thetreatment of GBM

$178,234
Loic Pierre Deleyrolle · University Of Florida · R21 · FY2023 · CA

Core B - Clinical Sample and Biostatistics Core

$178,175
Bob S Carter · Massachusetts General Hospital · P01 · FY2017 · CA

The Role of Non-Coding RNA Editing in MET Signaling in NSCLC

$178,171
Mario Acunzo · Virginia Commonwealth University · R21 · FY2024 · CA

Characterizing and Targeting Tumoral Factors Recruiting Perivascular Progenitors

$178,146
Manish Aghi · University Of California, San Francisco · K02 · FY2011 · NS

Characterizing and Targeting Tumoral Factors Recruiting Perivascular Progenitors

$178,146
Manish Aghi · University Of California, San Francisco · K02 · FY2010 · NS

Characterizing and Targeting Tumoral Factors Recruiting Perivascular Progenitors

$178,146
Manish Aghi · University Of California, San Francisco · K02 · FY2009 · NS

Mapping Single Extracellular Vesicles to Parent Cells for Immunotherapy Monitoring

$178,080
Jina Ko · Massachusetts General Hospital · K99 · FY2021 · CA

High-Resolution CGH Charaterization of Brain Tumors

$178,063
Duke University · R21 · FY2005 · NS

Imaging

$178,058
Christopher T Whitlow · Wake Forest University Health Sciences · P01 · FY2019 · CA

Core 1: Biospecimen and Pathology Core

$178,039
Harry Vinters · University Of California Los Angeles · P50 · FY2020 · CA

Novel genetic dependencies in VRK2 methylated glioblastoma multiforme

$178,000
William C Hahn · Dana-Farber Cancer Inst · R03 · FY2020 · TR

Genetic Modifiers of Immune Evasion by Cytomegalovirus in Glioblastoma

$177,922
Janardan P Pandey · Medical University Of South Carolina · R21 · FY2013 · NS

IMMUNOBIOLOGY OF MALIGNANT GLIOMA

$177,876
Gavin Peter Dunn · Washington University · K08 · FY2018 · NS

IMMUNOBIOLOGY OF MALIGNANT GLIOMA

$177,876
Gavin Peter Dunn · Washington University · K08 · FY2017 · NS

IMMUNOBIOLOGY OF MALIGNANT GLIOMA

$177,876
Gavin Peter Dunn · Washington University · K08 · FY2019 · NS

Small molecule inhibitors with a therapeutic window for EGFR signaling variants in glioblastoma

$177,839
Michael J Eck · Brigham And Women'S Hospital · U19 · FY2022 · CA

Toward Multi-Center MR Brain Perfusion

$177,738
Steven Stufflebeam · Massachusetts General Hospital · R01 · FY2013 · NS

Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas

$177,624
Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Central Nervous System Drug Delivery Techniques

$177,510
John Heiss · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS

Antibodies, B cells and resistance to human cryptococcosis

$177,490
Liise-Anne Pirofski · Albert Einstein College Of Medicine · R01 · FY2022 · AI

Novel Approaches to Modeling and Treating IDH1 Mutant Glioma

$177,473
Samuel Kent McBrayer · Ut Southwestern Medical Center · K22 · FY2020 · CA

Novel Approaches to Modeling and Treating IDH1 Mutant Glioma

$177,473
Samuel Kent McBrayer · Ut Southwestern Medical Center · K22 · FY2019 · CA

Mass Spectrometry, Proteomics and Metabolomics Core

$177,382
John M Asara · Brigham And Women'S Hospital · P01 · FY2014 · CA